← Open Payments lookup

AMY PAUL: Open Payments

NPI 1265002018 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,271 in 237 payments from 19 companies in 2025. Trend: 2023 $2,586 · 2024 $2,201 · 2025 $4,271

Food & beverage: $4,271
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.52$734
Axsome Therapeutics, Inc.33$733
Otsuka America Pharmaceutical, Inc.17$326
ABBVIE INC.21$301
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$294
Janssen Pharmaceuticals, Inc11$255
Alkermes, Inc.16$228
Lundbeck LLC12$208
Teva Pharmaceuticals USA, Inc.9$206
Corium, LLC10$175

Products named: INGREZZA, Auvelity, REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, ARISTADA, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.